A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia
- 1.6k Downloads
[18F]-fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) is a widely used diagnostic tool that can detect and quantify pathophysiology, as assessed through changes in cerebral glucose metabolism. [18F]-FDG PET scans can be analyzed using voxel-based statistical methods such as Statistical Parametric Mapping (SPM) that provide statistical maps of brain abnormalities in single patients. In order to perform SPM, a “spatial normalization” of an individual’s PET scan is required to match a reference PET template. The PET template currently used for SPM normalization is based on [15O]-H2O images and does not resemble either the specific metabolic features of [18F]-FDG brain scans or the specific morphological characteristics of individual brains affected by neurodegeneration. Thus, our aim was to create a new [18F]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both age-matched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template—at the single-subject and group level—independently for subjects with Mild Cognitive Impairment (MCI), probable Alzheimer’s Disease (AD), Frontotemporal lobar degeneration (FTLD) and dementia with Lewy bodies (DLB). We found a significant statistical effect of the population-specific FDG template-based normalisation in key anatomical regions for each dementia subtype, suggesting that spatial normalization with the new template provides more accurate estimates of metabolic abnormalities for single-subject and group analysis, and therefore, a more effective diagnostic measure.
Keywords18F-FDG PET SPM (RRID:nif-0000-00343) Spatial normalization Template Dementia
We thank the EADC-PET Consortium (Alexander Drzezga and Robert Perneczky [Munich], Mira Didic and Eric Guedj [Marseilles], Bart N. Van Berckel and Rik Ossenkoppele [Amsterdam], Flavio Nobili and Silvia Morbelli [Genoa], Giovanni Frisoni, Anna Caroli [Brescia]) for kindly providing EADC-PET imaging data for the purposes of the current study. This study was supported in part by the 6th European Framework Program Network of Excellence “DIMI” LSHB-CT-2005-512146, and the 7th Framework Programme for Research and Technological Development “DECIDE” RI-261593 and in part by the Italian Ministry of Education in the framework of the Project of Strategic National Interest “Invecchiamento: innovazioni tecnologiche e molecolari per un miglioramento della salute dell’anziano” allocated to the National Research Council. Karl Friston and John Ashburner are based at The Wellcome Trust Centre for Neuroimaging, which is supported by core funding from the Wellcome Trust [091593/Z/10/Z].
Conflict of Interest
The authors declare that they have no conflict of interest.
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
- Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 270–279.CrossRefGoogle Scholar
- Anchisi, D., Borroni, B., Franceschi, M., Kerrouche, N., Kalbe, E., Beuthien-Beumann, B., Cappa, S., et al. (2005). Heterogeneity of brain glucose metaboism in mild cognitive impairment and clinical progression to Alzheimer disease. Archives of Neurology, 62(11), 1728–1733.PubMedCrossRefGoogle Scholar
- Buchert, R., Wilke, F., Chakrabarti, B., Martin, B., Brenner, W., Mester, J., & Clausen, M. (2005). Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer’s disease. Journal of Neuroimaging, 15, 348–355.PubMedCrossRefGoogle Scholar
- Evans, A. C., Collins, D. L., Mills, S. R., Brown, E. D., Kelly, R. L., & Peters, T. M. (1993). 3D statistical neuroanatomical models from 305 MRI volumes. IEEE-Nuclear Science Symposium and Medical Imaging Conference Proceeding, 1813–1817.Google Scholar
- Jack, C. R., Jr., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., et al. (2011). Introduction to the recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 257–262.CrossRefGoogle Scholar
- Martino, M. E., Guzman de Villoria, J., Lacalle-Aurioles, M., Olazaran, J., Cruz, I., Navarro, E., et al. (2013). Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls. Annals of Nuclear Medicine. doi: 10.1007/s12149-013-0723-7.PubMedGoogle Scholar
- McKhann, G. M., Albert, M. S., Grossman, M., Miller, B., Dickson, D., & Trojanowski, J. Q. (2001). Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Archives of Neurology, 58, 1803–1809.PubMedCrossRefGoogle Scholar
- McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr., Kawas, C. H., Klunk, W. E., et al. (2011). The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging– Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269.CrossRefGoogle Scholar
- Perani, D. (2008). Functional neuroimaging of cognition. In: M. J. Aminoff, F. Boller, & D. F. Swaab (Eds.), Handbook of Clinical Neurology (pp.61–111). Elsevier.Google Scholar
- Prince, M., Bryce, R., & Ferr, C. (2011). The benefits of early diagnosis and intervention. In: Alzheimer’s Disease International World Alzheimer Report 2011. Institute of Psychiatry. King’s College London. Alzheimer’s Disease International.Google Scholar
- Signorini, M., Paulesu, E., Friston, K., Perani, D., Colleluori, A., Lucignani, G., et al. (1999). Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. NeuroImage, 9(1), 63–80.PubMedCrossRefGoogle Scholar
- Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Towards defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 280–292.Google Scholar
- Wenzel, F., Young, S., Wilke, F., Apostolova, I., Arlt, S., Jahn, H., et al. (2010). B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: impact on voxel-based statistical single-subject analysis. NeuroImage, 50(3), 994–1003.PubMedCrossRefGoogle Scholar
- Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256(3), 240–246.PubMedCrossRefGoogle Scholar
- Yakushev, I., Hammers, A., Fellgiebel, A., Schmidtmann, I., Scheurich, A., Buchholz, H. G., et al. (2009). SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnesic mild cognitive impairment from healthy aging. NeuroImage, 44(1), 43–50.PubMedCrossRefGoogle Scholar